NCT05532306View on ClinicalTrials.gov

Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 11, 2020

Primary Completion Date

November 23, 2020

Study Completion Date

November 23, 2020

Conditions
Healthy Subjects
Interventions
DRUG

Ribavirin 400 mg film coated tablet (1*400mg)

an immediate release film-coated tablet containing 400 mg Ribavirin

DRUG

Copegus® 200 mg film coated tablet (2*200mg)

an immediate release film-coated tablet containing 200 mg Ribavirin

Trial Locations (1)

11835

Future Research Center (FRC), Cairo

All Listed Sponsors
lead

Future University in Egypt

OTHER

NCT05532306 - Bioequivalence Study of Ribavirin in Healthy Adult Subjects Under Fed Condition | Biotech Hunter | Biotech Hunter